List of bibliographic references
Number of relevant bibliographic references: 28.
[0-20] [
0 - 20][
0 - 28][
20-27][
20-40]
| Ident. | Authors (with country if any) | Title |
|---|
| 000420 (2003) |
Ekachai Jenwitheesuk [États-Unis] ; Ram Samudrala | Identifying inhibitors of the SARS coronavirus proteinase. |
| 000F53 (2005) |
Li-Rung Chen [République populaire de Chine] ; Yu-Chin Wang ; Yi Wen Lin ; Shan-Yen Chou ; Shyh-Fong Chen ; Lee Tai Liu ; Ying-Ta Wu ; Chih-Jung Kuo ; Tom Shieh-Shung Chen ; Shin-Hun Juang | Synthesis and evaluation of isatin derivatives as effective SARS coronavirus 3CL protease inhibitors. |
| 001021 (2005) |
Jiun-Jie Shie [Taïwan] ; Jim-Min Fang ; Chih-Jung Kuo ; Tun-Hsun Kuo ; Po-Huang Liang ; Hung-Jyun Huang ; Wen-Bin Yang ; Chun-Hung Lin ; Jiun-Ling Chen ; Yin-Ta Wu ; Chi-Huey Wong | Discovery of potent anilide inhibitors against the severe acute respiratory syndrome 3CL protease. |
| 001230 (2005) |
Ulrich Kaeppler [Allemagne] ; Nikolaus Stiefl ; Markus Schiller ; Radim Vicik ; Alexander Breuning ; Werner Schmitz ; Daniel Rupprecht ; Carsten Schmuck ; Knut Baumann ; John Ziebuhr ; Tanja Schirmeister | A new lead for nonpeptidic active-site-directed inhibitors of the severe acute respiratory syndrome coronavirus main protease discovered by a combination of screening and docking methods. |
| 001497 (2006) |
Samer I. Al-Gharabli [Allemagne] ; Syed T Ali Shah ; Steffen Weik ; Marco F. Schmidt ; Jeroen R. Mesters ; Daniel Kuhn ; Gerhard Klebe ; Rolf Hilgenfeld ; Jörg Rademann | An efficient method for the synthesis of peptide aldehyde libraries employed in the discovery of reversible SARS coronavirus main protease (SARS-CoV Mpro) inhibitors. |
| 001623 (2006) |
I-Lin Lu [République populaire de Chine] ; Neeraj Mahindroo ; Po-Huang Liang ; Yi-Hui Peng ; Chih-Jung Kuo ; Keng-Chang Tsai ; Hsing-Pang Hsieh ; Yu-Sheng Chao ; Su-Ying Wu | Structure-based drug design and structural biology study of novel nonpeptide inhibitors of severe acute respiratory syndrome coronavirus main protease. |
| 001859 (2007) |
Qi-Shi Du [République populaire de Chine] ; Hao Sun ; Kuo-Chen Chou | Inhibitor design for SARS coronavirus main protease based on "distorted key theory". |
| 001A48 (2007) |
Yi-Ming Shao [République populaire de Chine] ; Wen-Bin Yang ; Hung-Pin Peng ; Min-Feng Hsu ; Keng-Chang Tsai ; Tun-Hsun Kuo ; Andrew H-J Wang ; Po-Huang Liang ; Chun-Hung Lin ; An-Suei Yang ; Chi-Huey Wong | Structure-based design and synthesis of highly potent SARS-CoV 3CL protease inhibitors. |
| 001B84 (2008) |
Jianmin Zhang [Canada] ; Carly Huitema ; Chunying Niu ; Jiang Yin ; Michael N G. James ; Lindsay D. Eltis ; John C. Vederas | Aryl methylene ketones and fluorinated methylene ketones as reversible inhibitors for severe acute respiratory syndrome (SARS) 3C-like proteinase. |
| 001B98 (2008) |
Yi-Ming Shao [Taïwan] ; Wen-Bin Yang [Taïwan] ; Tun-Hsun Kuo [Taïwan] ; Keng-Chang Tsai [Taïwan] ; Chun-Hung Lin [Taïwan] ; An-Suei Yang [Taïwan] ; Po-Huang Liang [Taïwan] ; Chi-Huey Wong [Taïwan, États-Unis] | Design, synthesis, and evaluation of trifluoromethyl ketones as inhibitors of SARS-CoV 3CL protease |
| 001C26 (2008) |
Carly Huitema [Canada] ; Jianmin Zhang ; Jiang Yin ; Michael N G. James ; John C. Vederas ; Lindsay D. Eltis | Heteroaromatic ester inhibitors of hepatitis A virus 3C proteinase: Evaluation of mode of action. |
| 001C95 (2008) |
Usman Bacha [États-Unis] ; Jennifer Barrila ; Sandra B. Gabelli ; Yoshiaki Kiso ; L. Mario Amzel ; Ernesto Freire | Development of broad-spectrum halomethyl ketone inhibitors against coronavirus main protease 3CL(pro). |
| 001D60 (2008) |
Qingang Yang [République populaire de Chine] ; Lili Chen ; Xuchang He ; Zhenting Gao ; Xu Shen ; Donglu Bai | Design and synthesis of cinanserin analogs as severe acute respiratory syndrome coronavirus 3CL protease inhibitors. |
| 001D64 (2008) |
Kenichi Akaji [Japon] ; Hiroyuki Konno [Japon] ; Mari Onozuka [Japon] ; Ayumi Makino [Japon] ; Hiroyuki Saito [Japon] ; Kazuto Nosaka [Japon] | Evaluation of peptide-aldehyde inhibitors using R188I mutant of SARS 3CL protease as a proteolysis-resistant mutant |
| 001E87 (2009) |
Thomas Regnier [Japon] ; Diganta Sarma ; Koushi Hidaka ; Usman Bacha ; Ernesto Freire ; Yoshio Hayashi ; Yoshiaki Kiso | New developments for the design, synthesis and biological evaluation of potent SARS-CoV 3CL(pro) inhibitors. |
| 001F75 (2009) |
Arun K. Ghosh [États-Unis] ; Jun Takayama [États-Unis] ; Yoann Aubin [États-Unis] ; Kiira Ratia [États-Unis] ; Rima Chaudhuri [États-Unis] ; Yahira Baez [États-Unis] ; Katrina Sleeman [États-Unis] ; Melissa Coughlin [États-Unis] ; Daniel B. Nichols [États-Unis] ; Debbie C. Mulhearn [États-Unis] ; Bellur S. Prabhakar [États-Unis] ; Susan C. Baker [États-Unis] ; Michael E. Johnson [États-Unis] ; Andrew D. Mesecar [États-Unis] | Structure-Based Design, Synthesis, and Biological Evaluation of a Series of Novel and Reversible Inhibitors for the Severe Acute Respiratory Syndrome-Coronavirus Papain-Like Protease |
| 002081 (2010) |
Holger Steuber [Allemagne] ; Rolf Hilgenfeld | Recent advances in targeting viral proteases for the discovery of novel antivirals. |
| 002144 (2010) |
R. Ramajayam [Taïwan] ; Kian-Pin Tan ; Hun-Ge Liu ; Po-Huang Liang | Synthesis, docking studies, and evaluation of pyrimidines as inhibitors of SARS-CoV 3CL protease. |
| 002232 (2010) |
R. Ramajayam [Taïwan] ; Kian-Pin Tan ; Hun-Ge Liu ; Po-Huang Liang | Synthesis and evaluation of pyrazolone compounds as SARS-coronavirus 3C-like protease inhibitors. |
| 002596 (2013) |
Jon Jacobs [États-Unis] ; Valerie Grum-Tokars ; Ya Zhou ; Mark Turlington ; S Adrian Saldanha ; Peter Chase ; Aimee Eggler ; Eric S. Dawson ; Yahira M. Baez-Santos ; Sakshi Tomar ; Anna M. Mielech ; Susan C. Baker ; Craig W. Lindsley ; Peter Hodder ; Andrew Mesecar ; Shaun R. Stauffer | Discovery, synthesis, and structure-based optimization of a series of N-(tert-butyl)-2-(N-arylamido)-2-(pyridin-3-yl) acetamides (ML188) as potent noncovalent small molecule inhibitors of the severe acute respiratory syndrome coronavirus (SARS-CoV) 3CL protease. |
| 002600 (2013) |
Sho Konno [Japon] ; Pillaiyar Thanigaimalai ; Takehito Yamamoto ; Kiyohiko Nakada ; Rie Kakiuchi ; Kentaro Takayama ; Yuri Yamazaki ; Fumika Yakushiji ; Kenichi Akaji ; Yoshiaki Kiso ; Yuko Kawasaki ; Shen-En Chen ; Ernesto Freire ; Yoshio Hayashi | Design and synthesis of new tripeptide-type SARS-CoV 3CL protease inhibitors containing an electrophilic arylketone moiety. |
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Ncbi/Curation
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i -k "Protease Inhibitors (chemical synthesis)"
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i \
-Sk "Protease Inhibitors (chemical synthesis)" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= SrasV1
|flux= Ncbi
|étape= Curation
|type= indexItem
|index= KwdEn.i
|clé= Protease Inhibitors (chemical synthesis)
}}
| This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021 |  |
